Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 2
Submit an article Journal homepage
12
Views
0
CrossRef citations to date
0
Altmetric
Articles

Additional left atrial septal line does not improve outcome of patients undergoing ablation for long-standing persistent atrial fibrillation

Evgeny MikhaylovDepartment of Electrophysiology and Cardiac Pacing, Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg, Russian Federation; The Netherlands.Correspondence[email protected].
, MD,
Sergey GureevDepartment of Electrophysiology and Cardiac Pacing, Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg, Russian Federation; The Netherlands.
, MD,
Tamas Szili-TorokDepartment of Cardiology, Electrophysiology Unit, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands.
, MD, PhD &
Dmitry LebedevDepartment of Electrophysiology and Cardiac Pacing, Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg, Russian Federation; The Netherlands.
, MD, PhD
Pages 153-160 | Received 08 Sep 2009, Published online: 23 May 2017

References

  • Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Hais-saguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2007; 4: 816–61.
  • Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, Bates ER, Lehmann MH, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V, Morady F. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006; 354: 934–41.
  • Oral H, Chugh A, Good E, Igic P, Elmouchi D, Tschopp DR, Reich SS, Bogun F, Pelosi F Jr, Morady F. Randomized comparison of encircling and nonencircling left atrial ablation for chronic atrial fibrillation. Heart Rhythm 2005; 2: 1165–72.
  • Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsa-neewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43: 2044–53.
  • Knecht S, Hocini M, Wright M, Lellouche N, O’Neill MD, Matsuo S, Nault I, Chauhan VS, Makati KJ, Bevilacqua M, Lim KT, Sacher F, Deplagne A, Derval N, Bordachar P, JaIs P, Clémenty J, Harissaguerre M. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J 2008; 29: 2359–66.
  • Sanders P, Jaris P, Hocini M, Hsu LF, Scavée C, Sacher F, Rotter M, Takahashi Y, Pasquié JL, Shah DC, Garrigue S, Clémenty J, Haïssaguerre M. Electrophysiologic and clinical consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation. Heart Rhythm 2004; 1: 176–84.
  • Verma A, Patel D, Famy T, Martin DO, Burkhardt JD, Elayi SC, Lakkireddy D, Wazni O, Cummings J, Schweikert RA, Saliba W, Tchou PJ, Natale A. Efficacy of adjuvant anteriorleft atrial ablation during intracardiac echocardiography-guided pulmonary vein antrum isolation for atrial fibrilla-tion. J Cardiovasc Electrophysiol 2007; 18: 151–6.
  • Harissaguerre M, Sanders P, Hocini M, Takahashi Y, Rotter M, Sacher F, Rostock T, Hsu LF, Bordachar P, Reuter S, Roudaut R, Clémenty J, JaIs P. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol 2005; 16: 1125–37.
  • Oral H, Chugh A, Yoshida K, Sarrazin JF, Kuhne M, Craw-ford T, Chalfoun N, Wells D, Boonyapisit W, Veerareddy S, Billakanty S, Wong WS, Good E, Jongnarangsin K, Pelosi F Jr, Bogun F, Morady F. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2009; 53: 782–9.
  • Elayi CS, Verma A, Di Biase L, Ching CK, Patel D, Barrett C, Martin D, Rong B, Fahmy TS, Khaykin Y, Hongo R, Hao S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Potenza D, Fanelli R, Massaro R, Arruda M, Schweikert RA, Natale A. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm 2008; 5: 1658–64.
  • Haissaguerre M, Marcus Fl, Fischer B, Clementy J. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: Report of three cases. J Cardiovasc Electrophysiol 1994; 5: 743–51.
  • Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572–6.
  • Nair M, Shah P, Batra R, Kumar M, Mohan J, Kaul U, Arora R. Chronic atrial fibrillation in patients with rheumatic heart disease: Mapping and radiofrequency ablation of flut-ter circuits seen at initiation after cardioversion. Circulation 2001; 104: 802–9.
  • Olgin JE, Jayachandran JV, Engesstein E, Groh W, Zipes DP. Atrial macroreentry involving the myocardium of the coronary sinus: A unique mechanism for atypical flutter. J Cardiovasc Electrophysiol 1998; 9: 1094–9.
  • Takahashi Y, Sanders P, Rotter M, Haissaguerre M. Dis-connection of the left atrial appendage for elimination of foci maintaining atrial fibrillation. J Cardiovasc Electro-physiol 2005; 16: 917–9.
  • Arya A, Piorkowski C, Sommer P, Kottkamp H, Hindricks G. Clinical implications of various follow up strategies after catheter ablation of atrial fibrillation. Pacing Clin Electro-physiol 2007; 30: 458–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.